The Glu-Glu Tag Monoclonal Antibody specifically recognizes the Glu-Glu epitope tag, a short peptide sequence derived from the polyoma virus medium T antigen. The tag’s core sequence is EYMPME (or CEEEEYMPME when including the N-terminal cysteine residue) . This epitope is genetically fused to target proteins during recombinant expression, enabling antibody-mediated detection and purification.
The antibody is validated for multiple applications:
Minimal steric interference due to the tag’s small size (6–10 amino acids) .
Compatible with insect, mammalian, and bacterial expression systems .
Protein Interaction Studies: Used to identify binding partners of Glu-Glu-tagged proteins in co-immunoprecipitation assays .
Subcellular Localization: Effectively visualized nuclear proteins (e.g., MRTF-B, NAC1) that were poorly detected by FLAG-tag antibodies .
Validation: Demonstrated specificity in studies by Wells et al. (2001) and Jeon et al. (2012), confirming minimal non-specific binding .
The Glu-Glu tag offers distinct advantages over larger tags (e.g., FLAG, HA):
Feature | Glu-Glu Tag | FLAG Tag |
---|---|---|
Size | 6–10 amino acids | 8 amino acids |
Nuclear Compatibility | High | Low (background issues) |
Antibody Affinity | 1–10 nM | ~1 nM |
The Glu-Glu epitope tag represents a short peptide sequence commonly recognized as EYMPME (or alternatively EMYMPE). This tag derives from a portion of the polyomavirus middle T antigen with the original sequence Glu-Glu-Glu-Glu-Tyr-Met-Pro-Met-Glu, which plays a role in cellular transformation. Monoclonal antibodies targeting this epitope have been designed to specifically recognize this sequence when engineered into recombinant proteins . The tag's small size (six amino acids) makes it particularly valuable for minimizing interference with target protein function while enabling various immunological detection and purification approaches .
The Glu-Glu tag offers several advantages compared to other tagging systems. Due to its small size (6 amino acids), it typically causes minimal interference with the structure and function of the tagged protein . Unlike some other systems such as the FLAG tag that has demonstrated limitations in nuclear protein detection (particularly in immunofluorescence applications), the Glu-Glu tag has shown reliable detection of nuclear proteins . This differential performance may be related to the abundance of arginine and lysine residues in nuclear proteins (>20% in histones), which potentially interfere with FLAG tag recognition . For researchers studying nuclear proteins, this makes the Glu-Glu tag system particularly valuable.
Two standard approaches are commonly employed to introduce the Glu-Glu tag into proteins of interest:
PCR-based oligonucleotide approach: This method utilizes oligonucleotides containing the Glu-Glu tag sequence (EYMPME) to amplify the gene of interest, ensuring in-frame expression. The tag sequence can be incorporated into either the forward or reverse primer, depending on whether N- or C-terminal tagging is desired .
Expression vector system: Alternatively, researchers can clone their gene of interest into a vector already containing the Glu-Glu tag sequence. This approach simplifies the process and reduces the risk of PCR-introduced errors .
When designing your expression construct, critical factors include:
Confirming in-frame fusion of the tag with the protein coding sequence
Ensuring proper stop codon placement
Strategic positioning of the tag (typically at N- or C-terminus) to minimize interference with protein function
The position of the Glu-Glu tag significantly impacts protein expression, function, and detection. Consider the following factors when determining tag placement:
Functional domains: Avoid placing the tag near known functional domains, active sites, or binding interfaces that could interfere with protein activity.
Protein termini accessibility: Choose between N- and C-terminal tagging based on the natural accessibility of these regions in your protein. For membrane proteins, consider which terminus faces the cytoplasm for improved detection.
Protein localization signals: Be aware that tags may mask or interfere with endogenous localization signals (such as nuclear localization sequences or secretion signals) if placed at the terminus containing such signals .
Folding considerations: Some proteins are sensitive to N-terminal modifications that can affect folding kinetics. In such cases, C-terminal tagging may be preferable .
Detecting nuclear proteins using epitope tags can be challenging due to the nuclear environment's properties. To maximize Glu-Glu-tagged nuclear protein detection:
Fixation optimization: For nuclear proteins, a combination of paraformaldehyde fixation (2-4%) followed by permeabilization with 0.1-0.5% Triton X-100 often yields optimal results.
Antibody selection: Choose high-affinity Glu-Glu monoclonal antibodies specifically validated for immunofluorescence applications. The search results indicate that G196 monoclonal antibody has demonstrated excellent nuclear protein detection in comparison studies .
Blocking optimization: Use BSA or normal serum from the species of your secondary antibody to reduce background. For nuclear proteins, adding 5-10% normal serum can significantly improve signal-to-noise ratio.
Signal amplification: For low-abundance nuclear proteins, consider tyramide signal amplification or use of highly sensitive fluorescent secondary antibodies.
The superior performance of the Glu-Glu tag system for nuclear protein detection is demonstrated in studies comparing it with the FLAG tag system. Researchers found that FLAG-tagged MRTF-B in cell nuclei stained more faintly compared to cytoplasmic protein, while the same protein with a Glu-Glu tag showed consistent detection in both compartments .
Purification of Glu-Glu-tagged proteins typically employs immunoaffinity chromatography with immobilized anti-Glu-Glu antibodies. The following protocol represents an optimized approach:
Materials:
Anti-Glu-Glu monoclonal antibody coupled to agarose/sepharose beads
Lysis buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, protease inhibitors
Wash buffer: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Triton X-100
Elution buffer options:
a) Low pH: 0.1 M glycine, pH 2.5-3.0
b) Peptide competition: 100-200 μg/ml synthetic Glu-Glu peptide
c) Water-miscible organic solvents (less denaturing alternative)
Procedure:
Prepare cell lysate in lysis buffer (1 hour at 4°C with gentle agitation)
Clear lysate by centrifugation (15,000 × g, 15 min)
Incubate cleared lysate with antibody-coupled beads (2-4 hours at 4°C with rotation)
Wash beads 3-5 times with wash buffer
Elute with chosen elution method:
Combinatorial tagging—utilizing multiple tags on a single protein—offers powerful advantages for complex research applications. When implementing Glu-Glu tag in combinatorial approaches, consider these strategic options:
Purification and visualization combinations: Pair Glu-Glu with a fluorescent protein tag (e.g., GFP) to enable both immunoaffinity purification and direct visualization.
Sequential purification strategies: Combine Glu-Glu with another affinity tag (e.g., 6×His or MBP) positioned at the opposite terminus to enable tandem purification schemes, significantly enhancing purity for structural biology applications .
Solubility enhancement: For proteins prone to aggregation or insolubility, combine Glu-Glu with solubility-enhancing tags such as MBP, SUMO, or Thioredoxin. This approach maintains the detection capabilities while improving protein expression and solubility .
Cleavable tag designs: Incorporate a protease recognition sequence (e.g., TEV or PreScission) between the Glu-Glu tag and your protein of interest to enable tag removal after purification.
When designing combinatorial tag systems, careful consideration of tag positioning is critical. The following table outlines recommended configurations based on experimental goals:
Experimental Goal | Recommended Tag Combination | Optimal Configuration |
---|---|---|
High-purity structural studies | Glu-Glu + His6 | N-terminal Glu-Glu, C-terminal His6 |
Protein localization studies | Glu-Glu + fluorescent protein | C-terminal Glu-Glu, N-terminal fluorescent protein |
Protein-protein interaction | Glu-Glu + FLAG or HA | Tags at opposite termini |
Improved expression/solubility | MBP + Glu-Glu | N-terminal MBP, C-terminal Glu-Glu |
This combinatorial approach enables researchers to capitalize on the unique advantages of multiple tagging systems while minimizing their individual limitations .
Cross-reactivity issues can complicate experiments using Glu-Glu tag antibodies. Analysis has shown that monoclonal antibodies against epitope tags can sometimes recognize endogenous proteins containing similar epitope sequences. For example, a search of the UniProtKB/Swiss-Prot database revealed potential cross-reactivity with 11 human proteins containing similar sequences to certain epitope tags .
To address potential cross-reactivity:
Pre-adsorption testing: Before using Glu-Glu antibodies in a new cell line or tissue, conduct Western blot analysis of untransfected/wild-type samples to identify potential cross-reactive bands.
Blocking with competing peptides: Include control samples where the antibody has been pre-incubated with excess synthetic Glu-Glu peptide to verify specificity of observed signals.
Alternative detection methods: Complement antibody-based detection with other methods such as mass spectrometry to confirm protein identity.
Multiple antibody validation: Use multiple anti-Glu-Glu antibodies from different sources or different clones to confirm specificity of detection.
Negative controls: Always include untagged protein controls to establish baseline and differentiate specific from non-specific signals .
When facing challenges with low expression or poor detection of Glu-Glu-tagged proteins, consider the following methodical troubleshooting approach:
Verify construct design:
Expression optimization:
Test different expression conditions (temperature, induction time)
Consider codon optimization for the expression system
Evaluate alternative tag positions (N- vs C-terminal)
Protein stability assessment:
Analyze protein half-life (cycloheximide chase)
Check for degradation products by Western blot
Add proteasome inhibitors to determine if low levels are due to degradation
Detection enhancement:
Subcellular localization considerations:
For nuclear proteins, use specialized nuclear extraction buffers
For membrane proteins, ensure proper solubilization with appropriate detergents
Consider if compartmentalization is reducing apparent expression levels
If expression issues persist despite these optimizations, consider potential fundamental issues such as protein toxicity, mRNA instability, or interference of the tag with protein folding .
To maintain optimal Glu-Glu tag antibody performance over time:
Storage temperature: Store antibodies at the recommended temperature, typically between 2-8°C for working solutions and -20°C for long-term storage of concentrated stocks .
Buffer composition: Most commercial Glu-Glu antibodies are supplied in phosphate-buffered solution with preservatives such as 0.03% Thimerosal or 0.02% Proclin300, often with stabilizers like 50% Glycerol or 1% BSA .
Freeze-thaw cycles: Minimize freeze-thaw cycles as they can reduce antibody activity. Aliquot antibodies before freezing for single-use portions.
Working dilution preparation: When preparing working dilutions, use fresh, cold buffer containing carrier protein (0.1-1% BSA) to prevent adsorption to tubes and maintain stability.
Contamination prevention: Use sterile technique when handling antibody solutions to prevent microbial contamination.
Long-term storage considerations: For the Glu-Glu monoclonal antibody, storage at -20°C for up to one year is typically recommended, though specific products may have different optimal conditions .
Following manufacturer-specific storage recommendations is crucial, as formulations may vary between suppliers. Note that some manufacturers have updated storage recommendations from -20°C to 2-8°C for certain antibody formulations, highlighting the importance of checking product-specific guidelines .
For protein-protein interaction studies using Glu-Glu-tagged proteins:
Co-immunoprecipitation optimization:
Bait protein considerations:
Position the Glu-Glu tag away from known interaction domains
Validate that the tagged protein maintains expected subcellular localization
Confirm biological activity of the tagged protein before interaction studies
Proximity-based approaches:
Combine Glu-Glu tagging with proximity labeling methods (BioID, APEX) for identifying weak or transient interactors
Implement dual-tagging strategies where both potential interacting partners carry different tags for reciprocal validation
Quantitative analysis:
Include appropriate negative controls (non-specific IgG, unrelated tagged protein)
Consider quantitative mass spectrometry approaches like SILAC or TMT labeling to distinguish specific from non-specific interactors
When employing Glu-Glu-tagged proteins for interaction studies in human cells, researchers should be aware of potential cross-reactions with endogenous proteins. The search results indicate that careful controls are necessary when using Glu-Glu-tagged proteins to search for binding partners, particularly in human cell systems .
The biochemical properties of the Glu-Glu tag have significant implications for structural biology applications:
Size and charge considerations:
The Glu-Glu tag contains multiple acidic residues, creating a negatively charged region that can affect protein behavior in certain buffer systems
At 6 amino acids (EYMPME), the tag is sufficiently small to minimize structural perturbations in most proteins
For crystallography studies, the small size reduces the likelihood of interfering with crystal packing
Structural flexibility:
The tag likely adopts a flexible, unstructured conformation when attached to proteins
This flexibility can be advantageous for accessibility during antibody binding but may introduce disorder in X-ray crystallography
Consider incorporating a cleavable linker for removing the tag after purification but before crystallization attempts
Buffer compatibility:
The acidic nature of the tag may affect protein behavior at pH values near the pKa of glutamic acid
For structural applications, test buffer systems with different pH values and ionic strengths to optimize protein stability
When using water-miscible organic solvents for elution, carefully evaluate the impact on protein structure
NMR considerations:
For NMR studies, the additional residues from the tag will contribute signals that must be accounted for
The tag may introduce local chemical shift perturbations in nearby residues
Consider deuteration strategies if using the tag for proteins studied by NMR
Recent advancements in affinity tagging systems have demonstrated that structural knowledge of antibody-tag interactions can inform better tag design. For structural applications, researchers have successfully used concatenation of short recognition sequences to engineer tags with ideal solution binding kinetics, enabling efficient purification with non-denaturing elution conditions .
Research has demonstrated significant differences in the performance of various epitope tag systems when detecting nuclear proteins. This comparative analysis highlights key findings:
Nuclear protein detection efficiency:
Studies have shown that the FLAG tag system can be inadequate for immunofluorescence detection of nuclear proteins, with FLAG-tagged nuclear proteins staining notably more faintly than their cytoplasmic counterparts
In direct comparison studies, Glu-Glu-tagged nuclear proteins like NAC1 and ATF1 exhibited robust nuclear staining, demonstrating superior performance for nuclear localization studies
Mechanistic basis for differential performance:
The high abundance of arginine and lysine in the nuclear environment (>20% of amino acids in histone proteins) may interfere with FLAG tag recognition
Arginine at mild pH can effectively dissociate FLAG-tagged proteins from anti-FLAG antibodies, potentially explaining the reduced nuclear detection efficiency
Nuclear proteins can constitute up to 55% of total nuclear content, creating a potentially interfering environment for certain tag systems
Experimental validation:
When researchers changed from FLAG-tagged to Glu-Glu-tagged MRTF-B (a nuclear-cytoplasmic shuttle protein), they observed dramatically improved detection of the nuclear fraction
This allowed more accurate evaluation of relative subcellular distribution, critical for studies of protein trafficking and localization
These findings suggest that researchers studying nuclear proteins or proteins that shuttle between nucleus and cytoplasm should consider the Glu-Glu tag system as a preferred approach for immunofluorescence applications.
While not a Glu-Glu tag system, the recently developed G196 epitope tag system offers instructive comparisons that inform tag selection decisions. The G196 system, based on a monoclonal antibody recognizing the five amino acid sequence Asp-Leu-Val-Pro-Arg, demonstrates several key advantages:
High affinity and specificity:
Versatility across experimental systems:
Nuclear protein detection capabilities:
Understanding the comparative advantages of different tagging systems allows researchers to make informed choices based on their specific experimental requirements, target protein properties, and cellular localization patterns.